Matches in Nanopublications for { ?s ?p "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1089428.RAWWp0P3PqR3mLj4VpU1RlDXep_tb61_3eD094zIoAcfs130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089428.RAWWp0P3PqR3mLj4VpU1RlDXep_tb61_3eD094zIoAcfs130_provenance.
- NP1089434.RAZBijinwPJRi-x5GOhXIjZoi41JESRJv6sxC1kGyhWcg130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089434.RAZBijinwPJRi-x5GOhXIjZoi41JESRJv6sxC1kGyhWcg130_provenance.
- NP1089437.RAW9rqrsMQZrv-lvoNyGzBdXw6cks0VgdQ6EtKOi3So0U130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089437.RAW9rqrsMQZrv-lvoNyGzBdXw6cks0VgdQ6EtKOi3So0U130_provenance.
- NP836533.RAol6TPpme3DSCz7kirA-w4vUqRO9B43Sqq0i-GqEctKo130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836533.RAol6TPpme3DSCz7kirA-w4vUqRO9B43Sqq0i-GqEctKo130_provenance.
- NP638426.RAKamyNciKoTrZPdx8y4HjcE13j0_vUykkmGMa-Q7Zs-Y130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638426.RAKamyNciKoTrZPdx8y4HjcE13j0_vUykkmGMa-Q7Zs-Y130_provenance.
- NP638429.RAEGHtH9XXyYy6xkpo3G8g-xgczbuH-G7lgfJp9vm1SdA130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638429.RAEGHtH9XXyYy6xkpo3G8g-xgczbuH-G7lgfJp9vm1SdA130_provenance.
- NP836535.RAzPDGV4Ja9kgNmntGujjqm59X84zW6olr4k-138abhyo130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836535.RAzPDGV4Ja9kgNmntGujjqm59X84zW6olr4k-138abhyo130_provenance.
- NP1089439.RAy672fhiETN8L7P7gGTpVPzv5yNhMmcU8kHsh25xE4Z0130_assertion description "[Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089439.RAy672fhiETN8L7P7gGTpVPzv5yNhMmcU8kHsh25xE4Z0130_provenance.